BDSX
BIODESIX INC
BIODESIX INC (BDSX) has 7 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 2, 2026.
- Industry:Medical - Diagnostics & Research
- CEO:Scott Hutton
- Employees:334
- HQ:Boulder, CO, US
- IPO:2020-10-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$43K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$230.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Hutton ScottFirst filing | President & CEO | Sale | 1,490 | $19K | Feb 23 | SEC ↗ |
Cowie Robin HarperFirst filing | CFO, Sec'y & Treasurer | Sale | 535 | $7K | Feb 23 | SEC ↗ |
Vazquez ChrisFirst filing | Chief Accounting Officer | Sale | 211 | $3K | Feb 23 | SEC ↗ |
Pestano Gary AnthonyFirst filing | Chief Development Officer | Sale | 556 | $7K | Feb 23 | SEC ↗ |
O'Kane KieranFirst filing | Chief Commercial Officer | Sale | 535 | $7K | Feb 23 | SEC ↗ |
Related companies
BIODESIX INC is in the Healthcare sector.